01 4Merck Canada Inc.
02 1Blank
01 32179396
02 12305803
03 12443089
01 2POSACONAZOLE
02 3Posaconazole
01 1SOLUTION
02 3Suspension
03 1TABLET
01 32014-12-20
02 12018-10-05
03 12022-04-01
Patent Expiration Date : 2018-10-05
Date Granted : 2009-12-22
Brand Name : POSANOL
Patent Number : 2305803
Filing Date : 1998-10-05
Strength per Unit : 40mg / ml
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-10-05
Date Granted : 2009-12-22
Patent Expiration Date : 2014-12-20
Date Granted : 2001-04-17
Brand Name : POSANOL
Patent Number : 2179396
Filing Date : 1994-12-20
Strength per Unit : 40mg / ml
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-12-20
Date Granted : 2001-04-17
Patent Expiration Date : 2022-04-01
Date Granted : 2011-11-01
Brand Name : POSANOL
Patent Number : 2443089
Filing Date : 2002-04-01
Strength per Unit : 40mg / ml
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-04-01
Date Granted : 2011-11-01
Patent Expiration Date : 2014-12-20
Date Granted : 2001-04-17
Brand Name : POSANOL
Patent Number : 2179396
Filing Date : 1994-12-20
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2014-12-20
Date Granted : 2001-04-17
Patent Expiration Date : 2014-12-20
Date Granted : 2001-04-17
Brand Name : POSANOL
Patent Number : 2179396
Filing Date : 1994-12-20
Strength per Unit : 300 mg / vial (18 mg / mL)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2014-12-20
Date Granted : 2001-04-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
